Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for cerebral salt wasting in tuberculous meningitis
ISRCTN16770388Phase 2Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in cerebral salt-wasting syndrome (CSWS) and meningeal tuberculosis comparing Propranolol with Placebo (2 arms). Primary endpoint: Days to normalization of serum sodium. Started Mar 2022; status: completed.
02
Drugs
propranolol
03
Conditions
cerebral salt-wasting syndrome (CSWS)meningeal tuberculosis
Beyond the preview
Go deeper on ISRCTN16770388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16770388.